deltatrials
Completed OBSERVATIONAL NCT03387722

Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study (SevEos)

Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study SevEos is a Cross-sectional, Multi-center, Non-interventional Study Aimed to Describe the Treatment Patterns in 250 Severe Asthma Patients Across the Gulf Region.

Sponsor: AstraZeneca

Conditions Severe Asthma
Updated 15 times since 2018 Last updated: Sep 8, 2020 Started: Dec 31, 2017 Primary completion: Jan 3, 2019 Completion: Jan 3, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03387722, this observational or N/A phase trial focuses on Severe Asthma and remains completed. Sponsored by AstraZeneca, it has been updated 15 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2018 – ~Feb 2018 · 31 days · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Oct 2020 · 19 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Oct 2020 — Jan 2021 [monthly]

    Completed

  5. Mar 2019 — Oct 2020 [monthly]

    Completed

    Status: Recruiting → Completed

▶ Show 10 earlier versions

  1. Jan 2019 — Mar 2019 [monthly]

    Recruiting

  2. Dec 2018 — Jan 2019 [monthly]

    Recruiting

  3. Nov 2018 — Dec 2018 [monthly]

    Recruiting

  4. Oct 2018 — Nov 2018 [monthly]

    Recruiting

  5. Sep 2018 — Oct 2018 [monthly]

    Recruiting

  6. Aug 2018 — Sep 2018 [monthly]

    Recruiting

  7. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  8. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  9. Feb 2018 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Jan 2018 — Feb 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations